Trending
- Sequencing Treatment after EV-Pembro in Urothelial Carcinoma
- Real-World Outcomes With Atezolizumab Plus Bevacizumab vs Durvalumab-Based Therapy
- Relapsed/Refractory Multiple Myeloma: Recognizing and Managing Neurologic Events With GPRC5D-Directed Therapy
- Mitigating Stomatitis and Optimizing Gedatolisib Treatment in Breast Cancer
- RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration
- Relapsed/Refractory Multiple Myeloma: Emerging Combination Strategies With Talquetamab
- Applying Real-World Evidence to Frontline Regimen Selection in HCC
- The PLAU-ITGB1-TGF-β axis orchestrates spatiotemporal reprogramming of fibroblasts at the invasive front to drive dual immunosuppressive niche and immunotherapy resistance in oral squamous cell carcinoma
Friday, July 17